Veristat has participated in over 225 clinical trials since the year 2000, ranging from small Phase I trials to large international Phase III and IV programs.
Veristat’s therapeutic areas of expertise include, but are not limited to:
- Allergy
- Anti-infective
- Biodefense
- Cardiovascular
- Diagnostic Agents
- Gastrointestinal
- HIV/AIDS
- Leukemias
- Lymphomas
- Medical Devices
- Metabolic and Endocrine Disease
- Reproductive Health
- Respiratory
- Rheumatoid Arthritis
- Solid Tumors
- Transplantation
- Vaccines